By OctariusRx
Every March, the Malignant Hyperthermia Association of the United States (MHAUS) designates the month as Malignant Hyperthermia Awareness & Training Month to emphasize the importance of preparedness. In the high‑stakes setting of ambulatory surgery centers (ASCs), this observance matters more than ever.
What Is Malignant Hyperthermia (MH) and Why Does Awareness Matter?
MH is a rare but potentially life-threatening genetic disorder triggered by certain anesthetic agents (and, in rare cases, by other stressors). Once triggered, it can lead to rapid muscle rigidity, a dangerously high body temperature, organ failure, and death if untreated.
For ASCs or any facility where general anesthesia, inhaled agents, succinylcholine, or other triggering agents are used, the margins for error are small. March provides a timely reminder to increase vigilance around policies, training, and readiness.
Why This Matters in ASC Settings
- Preparation saves lives — MHAUS emphasizes that an MH crisis is best managed with preparation.
- Triggers can occur in routine cases — MH doesn’t always happen in major surgery; it can appear in what were thought to be low-risk procedures.
- Readiness aligns with accreditation and patient safety goals — Keeping MH protocols current adds a layer of quality assurance for your facility’s surgical care.
How Your ASC Can Observe March
Here are practical steps your center can implement during this awareness month:
- Conduct a mock MH drill: Walk through a scenario where MH is triggered mid-procedure. Review each team member’s role, the MH cart, medication (e.g., dantrolene), cooling measures, and documentation.
- Audit your MH crisis kit: Ensure the correct dose of dantrolene is stocked and easily accessible, that your supplies and monitoring gear are in good order, and that staff know where the kit is kept.
- Review and update your MH policy: Make sure your policy clearly outlines recognition (rigidity, rising ETCO₂, high temperature), activation protocol, documentation, and post-event debrief.
- Educate your team: Use March as the opportunity for short educational sessions or refresher training for all providers — anesthesia, OR staff, PACU, recovery room, and support staff.
- Screen patients and document risk: Encourage preoperative screening for history or family history of adverse anesthetic reactions or suspected MH. Make sure these flags are communicated to the anesthesia team and documented appropriately.
Key Takeaways
- MH is rare but critical — the window for intervention is narrow.
- March is an ideal time to refresh your readiness, audit supplies, update policies, and train staff.
- Every team member — surgeon, CRNA/MD anesthetist, perioperative nurse, technician — plays a role in identification and response.
- Complacency is a risk. Regular rehearsal, clarity of roles, and accurate documentation can make the difference.
Let’s Use March to Make a Difference
As we move through March, let the theme of MH Awareness & Training Month motivate proactive steps rather than reactive ones.
At OctariusRx, we’re here to support ASCs with MH readiness audits, policy reviews, and accreditation alignment. If you’d like help tailoring your facility’s MH readiness plan, let’s talk.
Contact us to schedule a readiness review.
The Consultant Pharmacists at OctariusRx provide guidance on safe medication management, survey readiness and cost savings to ambulatory healthcare facilities/surgery centers, senior care facilities and pharmacies . We also help individual patients optimize their medications to improve their quality of life and save money. Contact us for assistance.
